EP Index
EP Index
EP Index
INDEX
To aid users the index includes a reference to the supplement where the latest version of a text can be found.
For example: Acetone...............................................5.1-2875
means the monograph Acetone can be found on page 2875 of Supplement 5.1.
Note that where no reference for a supplement is made, the text can be found in the principal volume.
General Notices (1) apply to all monographs and other texts 3045
EUROPEAN PHARMACOPOEIA 5.1 Index
General Notices (1) apply to all monographs and other texts 3047
Index EUROPEAN PHARMACOPOEIA 5.1
3.1.13. Plastic additives ............................................................ 293 5.2.5. Substances of animal origin for the production of
3.1.14. Materials based on plasticised poly(vinyl chloride) veterinary vaccines.................................................................. 460
for containers for aqueous solutions for intravenous 5.2.6. Evaluation of safety of veterinary vaccines and
infusion ...................................................................................... 296 immunosera ....................................................................5.1-2827
3.1.15. Polyethylene terephthalate for containers for 5.2.7. Evaluation of efficacy of veterinary vaccines and
preparations not for parenteral use..................................... 298 immunosera .....................................................................5.1-2829
3.1.1. Materials for containers for human blood and blood 5.2.8. Minimising the risk of transmitting animal spongiform
components............................................................................... 269 encephalopathy agents via human and veterinary medicinal
3.1.3. Polyolefines...................................................................... 274 products ..................................................................................... 463
3.1.4. Polyethylene without additives for containers 5.2.9. Evaluation of safety of each batch of veterinary
for parenteral preparations and for ophthalmic vaccines and immunosera.............................................5.1-2830
preparations.............................................................................. 278 5.2. General texts on vaccines................................................. 453
3.1.5. Polyethylene with additives for containers 5.3. Statistical analysis of results of biological assays and
for parenteral preparations and for ophthalmic tests............................................................................................. 475
preparations.............................................................................. 279 5.4. Residual solvents ............................................................... 507
3.1.6. Polypropylene for containers and closures for 5.5. Alcoholimetric tables .........................................................519
parenteral preparations and ophthalmic preparations ... 282 5.6. Assay of interferons........................................................... 533
3.1.7. Poly(ethylene - vinyl acetate) for containers and tubing 5.7. Table of physical characteristics of radionuclides
for total parenteral nutrition preparations ........................ 285 mentioned in the European Pharmacopoeia..................... 539
3.1.8. Silicone oil used as a lubricant ................................... 287 5.8. Pharmacopoeial harmonisation ..................................... 551
3.1.9. Silicone elastomer for closures and tubing .............. 288 5.9. Polymorphism..................................................................... 555
3.1. Materials used for the manufacture of containers ..... 269
3.2.1. Glass containers for pharmaceutical use .................. 303 A
3.2.2.1. Plastic containers for aqueous solutions for Abbreviations and symbols (1.5.).................................................9
parenteral infusion .................................................................. 309 Abnormal toxicity (2.6.9.)......................................................... 153
3.2.2. Plastic containers and closures for pharmaceutical Absinthii herba ........................................................................ 2710
use............................................................................................... 308 Absorption spectrophotometry, infrared (2.2.24.)................ 37
3.2.3. Sterile plastic containers for human blood and blood Absorption spectrophotometry, ultraviolet and visible
components............................................................................... 309 (2.2.25.) ........................................................................................ 38
3.2.4. Empty sterile containers of plasticised poly(vinyl Acacia............................................................................................ 905
chloride) for human blood and blood components...........311 Acaciae gummi .......................................................................... 905
3.2.5. Sterile containers of plasticised poly (vinyl chloride) Acaciae gummi dispersione desiccatum............................. 905
for human blood containing anticoagulant solution....... 312 Acacia, spray-dried ..................................................................... 905
3.2.6. Sets for the transfusion of blood and blood Acamprosate calcium ................................................................ 906
components................................................................................313 Acamprosatum calcicum......................................................... 906
3.2.8. Sterile single-use plastic syringes ................................314 Acarbose..............................................................................5.1-2873
3.2.9. Rubber closures for containers for aqueous parenteral Acarbosum .........................................................................5.1-2873
preparations, for powders and for freeze-dried powders ..316 Acebutolol hydrochloride......................................................... 907
3.2. Containers ........................................................................... 303 Acebutololi hydrochloridum .................................................. 907
4.1.1. Reagents ........................................................................... 321 Aceclofenac.................................................................................. 909
4.1.1. Reagents .................................................................. 5.1-2817 Aceclofenacum........................................................................... 909
4.1.2. Standard solutions for limit tests................................ 426 Acesulfame potassium ...............................................................911
4.1.2. Standard solutions for limit tests....................... 5.1-2818 Acesulfamum kalicum ..............................................................911
4.1.3. Buffer solutions .............................................................. 430 Acetazolamide............................................................................. 912
4.1. Reagents, standard solutions, buffer solutions ........... 321 Acetazolamidum........................................................................ 912
4.2.1. Primary standards for volumetric solutions............. 435 Acetic acid, glacial ......................................................................913
4.2.2. Volumetric solutions...................................................... 435 Acetic acid in synthetic peptides (2.5.34.) .............................141
4.2. Volumetric analysis............................................................ 435 Acetone................................................................................5.1-2875
4-Aminobenzoic acid ................................................................. 973 Acetonum ...........................................................................5.1-2875
4. Reagents.................................................................................. 321 Acetylcholine chloride ...............................................................914
5.10. Control of impurities in substances for pharmaceutical Acetylcholini chloridum...........................................................914
use............................................................................................... 559 Acetylcysteine ..............................................................................915
5.11. Characters section in monographs .............................. 565 Acetylcysteinum .........................................................................915
5.1.1. Methods of preparation of sterile products .............. 445 Acetylsalicylic acid ......................................................................917
5.1.2. Biological indicators of sterilisation........................... 447 Acetyltryptophan, N- ..................................................................918
5.1.3. Efficacy of antimicrobial preservation ....................... 447 Acetyltyrosine, N- ....................................................................... 920
5.1.4. Microbiological quality of pharmaceutical Aciclovir ....................................................................................... 921
preparations.............................................................................. 449 Aciclovirum ................................................................................ 921
5.1.5. Application of the F0 concept to steam sterilisation of Acidum 4-aminobenzoicum ................................................... 973
aqueous preparations ....................................................5.1-2821 Acidum aceticum glaciale........................................................913
5.1. General texts on sterility .................................................. 445 Acidum acetylsalicylicum ........................................................917
5.2.1. Terminology used in monographs on vaccines ....... 453 Acidum adipicum...................................................................... 926
5.2.2. Chicken flocks free from specified pathogens for the Acidum alginicum..................................................................... 942
production and quality control of vaccines...............5.1-2825 Acidum amidotrizoicum dihydricum .................................. 967
5.2.3. Cell substrates for the production of vaccines for Acidum aminocaproicum ....................................................... 974
human use................................................................................. 455 Acidum ascorbicum................................................................ 1025
5.2.4. Cell cultures for the production of veterinary Acidum asparticum ................................................................ 1029
vaccines...................................................................................... 458 Acidum benzoicum................................................................. 1072
Acidum boricum.......................................................................1117
General Notices (1) apply to all monographs and other texts 3049
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3051
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3053
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3055
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3057
Index EUROPEAN PHARMACOPOEIA 5.1
Containers of plasticised poly (vinyl chloride) for human Cysteini hydrochloridum monohydricum........................ 1381
blood containing anticoagulant solution, sterile (3.2.5.).. 312 Cystine........................................................................................1382
Contamination, microbial, test for specified micro-organisms Cystinum ...................................................................................1382
(2.6.13.) ...................................................................................... 156 Cytarabine .................................................................................1383
Contamination, microbial, total viable aerobic count Cytarabinum.............................................................................1383
(2.6.12.) ...................................................................................... 154
Content uniformity of single-dose preparations (2.9.6.).... 234 D
Control of impurities in substances for pharmaceutical use Dalteparin sodium ...................................................................1387
(5.10.).......................................................................................... 559 Dalteparinum natricum ........................................................1387
Copolymerum methacrylatis butylati basicum ............... 1053 Dapsone .....................................................................................1388
Copovidone................................................................................1363 Dapsonum.................................................................................1388
Copovidonum...........................................................................1363 Daunorubicin hydrochloride .................................................1389
Copper for homoeopathic preparations................................ 896 Daunorubicini hydrochloridum..........................................1389
Copper sulphate, anhydrous..................................................1364 D-Camphor ................................................................................. 1170
Copper sulphate pentahydrate..............................................1365 D-Camphora .............................................................................. 1170
Coriander ...................................................................................1365 Decylis oleas.............................................................................1390
Coriander oil .............................................................................1366 Decyl oleate ...............................................................................1390
Coriandri aetheroleum ..........................................................1366 Deferoxamine mesilate............................................................1390
Coriandri fructus ....................................................................1365 Deferoxamini mesilas ............................................................1390
Corpora ad usum pharmaceuticum ..................................... 586 Degree of coloration of liquids (2.2.2.).................................... 24
Cortisone acetate .....................................................................1367 Deliverable mass or volume of liquid and semi-solid
Cortisoni acetas.......................................................................1367 preparations, test for (2.9.28.)............................................... 263
Cotton, absorbent ....................................................................1369 Demeclocycline hydrochloride..............................................1392
Cottonseed oil, hydrogenated ..............................................1370 Demeclocyclini hydrochloridum ........................................1392
Couch grass rhizome .............................................................. 1371 Density of solids (2.2.42.)........................................................... 64
Crataegi folii cum flore extractum siccum....................... 1714 Density, relative (2.2.5.) .............................................................. 27
Crataegi folium cum flore..................................................... 1713 Dental type silica...................................................................... 2411
Crataegi fructus ....................................................................... 1712 Depressor substances (2.6.11.)................................................ 153
Creams.......................................................................................... 625 Deptropine citrate....................................................................1393
Cresol, crude ............................................................................. 1371 Deptropini citras .....................................................................1393
Cresolum crudum ................................................................... 1371 Dequalinii chloridum.............................................................1394
Croci stigma ad praeparationes homoeopathicas............ 900 Dequalinium chloride..............................................................1394
Croscarmellose sodium........................................................... 1371 Desipramine hydrochloride ...................................................1395
Crospovidone ............................................................................1373 Desipramini hydrochloridum ..............................................1395
Crospovidonum .......................................................................1373 Deslanoside ...............................................................................1396
Crotamiton ................................................................................ 1374 Deslanosidum ..........................................................................1396
Crotamitonum.......................................................................... 1374 Desmopressin............................................................................1397
Cupri sulfas anhydricus ........................................................1364 Desmopressinum.....................................................................1397
Cupri sulfas pentahydricus ..................................................1365 Desoxycortone acetate............................................................1399
Cuprum ad praeparationes homoeopathicas .................... 896 Desoxycortoni acetas .............................................................1399
Curcumae xanthorrhizae rhizoma.....................................2645 Detector tubes, gas (2.1.6.) .........................................................19
Cutaneous application, liquid preparations for................... 607 Determination of essential oils in vegetable drugs
Cutaneous application, powders for .......................................616 (2.8.12.) .......................................................................................217
Cutaneous application, semi-solid preparations for ........... 624 Determination of nitrogen by sulphuric acid digestion
Cutaneous application, veterinary liquid preparations (2.5.9.) ........................................................................................ 129
for ................................................................................................ 630 Determination of primary aromatic amino-nitrogen
Cutaneous foams........................................................................ 608 (2.5.8.) ........................................................................................ 129
Cyamopsidis seminis pulvis................................................. 1694 Determination of tannins in herbal drugs (2.8.14.)............ 221
Cyanocobalamin .......................................................................1375 Determination of water by distillation (2.2.13.) .................... 32
Cyanocobalamin (57Co) capsules .............................................819 Detomidine hydrochloride for veterinary use ................... 1400
Cyanocobalamin (57Co) solution ............................................. 820 Detomidini hydrochloridum ad usum veterinarium..... 1400
Cyanocobalamin (58Co) capsules ............................................ 821 Devil’s claw root ....................................................................... 1401
Cyanocobalamin (58Co) solution ............................................. 822 Dexamethasone ........................................................................ 1402
Cyanocobalamini (57Co) capsulae .........................................819 Dexamethasone acetate.......................................................... 1403
Cyanocobalamini (57Co) solutio ............................................ 820 Dexamethasone sodium phosphate ..................................... 1404
Cyanocobalamini (58Co) capsulae ........................................ 821 Dexamethasoni acetas ........................................................... 1403
Cyanocobalamini (58Co) solutio ............................................ 822 Dexamethasoni natrii phosphas ......................................... 1404
Cyanocobalaminum ...............................................................1375 Dexamethasonum ................................................................... 1402
Cyclizine hydrochloride.......................................................... 1376 Dexchlorpheniramine maleate .............................................. 1406
Cyclizini hydrochloridum..................................................... 1376 Dexchlorpheniramini maleas .............................................. 1406
Cyclopentolate hydrochloride ...............................................1377 Dexpanthenol............................................................................ 1407
Cyclopentolati hydrochloridum ..........................................1377 Dexpanthenolum..................................................................... 1407
Cyclophosphamide...................................................................1378 Dextran 1 for injection............................................................ 1408
Cyclophosphamidum .............................................................1378 Dextran 40 for injection ......................................................... 1409
Cyproheptadine hydrochloride .............................................1379 Dextran 60 for injection ......................................................... 1410
Cyproheptadini hydrochloridum ........................................1379 Dextran 70 for injection ..........................................................1411
Cyproterone acetate ................................................................1380 Dextrans, molecular mass distribution in (2.2.39.) .............. 57
Cyproteroni acetas..................................................................1380 Dextranum 1 ad iniectabile ................................................. 1408
Cysteine hydrochloride monohydrate ................................. 1381 Dextranum 40 ad iniectabile ............................................... 1409
General Notices (1) apply to all monographs and other texts 3059
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3061
Index EUROPEAN PHARMACOPOEIA 5.1
Fatty acids, composition by gas chromatography Filum polyamidicum-6/6 sterile in fuso ad usum
(2.4.22.) .......................................................................................110 veterinarium ............................................................................ 887
Fatty oils, alkaline impurities in (2.4.19.) ............................. 109 Filum polyamidicum-6 sterile in fuso ad usum
Fatty oils and herbal drugs, heavy metals in (2.4.27.) ........119 veterinarium ............................................................................ 886
Fatty oils and resinified essential oils in essential oils Finasteride.................................................................................1594
(2.8.7.)..........................................................................................216 Finasteridum............................................................................1594
Fatty oils, foreign oils in, by thin-layer chromatography Fish oil, rich in omega-3-acids...............................................1595
(2.4.21.) ...................................................................................... 109 Flecainide acetate ....................................................................1598
Fatty oils, identification by thin-layer chromatography Flecainidi acetas .....................................................................1598
(2.3.2.) .......................................................................................... 98 Flowability (2.9.16.) ................................................................... 242
Fatty oils, sterols in (2.4.23.) ..........................................5.1-2787 Flubendazole ............................................................................1599
Fc function of immunoglobulin, test for (2.7.9.) ................. 202 Flubendazolum........................................................................1599
Feline calicivirosis vaccine (inactivated) ............................... 757 Flucloxacillin sodium .......................................................5.1-2925
Feline calicivirosis vaccine (live), freeze-dried ..................... 758 Flucloxacillinum natricum............................................5.1-2925
Feline infectious enteritis (feline panleucopenia) vaccine Flucytosine ................................................................................ 1602
(inactivated) .............................................................................. 759 Flucytosinum ........................................................................... 1602
Feline infectious enteritis (feline panleucopenia) vaccine Fludarabine phosphate....................................................5.1-2926
(live) ............................................................................................ 760 Fludarabini phosphas .....................................................5.1-2926
Feline leukaemia vaccine (inactivated)...................................761 Fludeoxyglucose (18F) injection .............................................. 822
Feline panleucopenia vaccine (inactivated).......................... 759 Fludeoxyglucosi (18F) solutio iniectabilis ........................... 822
Feline panleucopenia vaccine (live) ....................................... 760 Fludrocortisone acetate.......................................................... 1603
Feline viral rhinotracheitis vaccine (inactivated) ................ 762 Fludrocortisoni acetas ........................................................... 1603
Feline viral rhinotracheitis vaccine (live), freeze-dried ...... 763 Flumazenil................................................................................. 1604
Felodipine .................................................................................. 1576 Flumazenil (N-[11C]methyl) injection ..................................... 825
Felodipinum ............................................................................. 1576 Flumazenil (N-[11C]methyl) solutio iniectabilis................. 825
Fenbendazole for veterinary use ..........................................1577 Flumazenilum.......................................................................... 1604
Fenbendazolum ad usum veterinarium............................1577 Flumequine ............................................................................... 1605
Fenbufen ....................................................................................1578 Flumequinum........................................................................... 1605
Fenbufenum..............................................................................1578 Flumetasone pivalate .............................................................. 1607
Fennel, bitter.............................................................................1580 Flumetasoni pivalas ............................................................... 1607
Fennel, sweet.............................................................................1580 Flunarizine dihydrochloride.................................................. 1608
Fenofibrate ................................................................................ 1581 Flunarizini dihydrochloridum ............................................ 1608
Fenofibratum............................................................................ 1581 Flunitrazepam........................................................................... 1609
Fenoterol hydrobromide.........................................................1583 Flunitrazepamum ................................................................... 1609
Fenoteroli hydrobromidum ..................................................1583 Flunixini megluminum ad usum veterinarium.......5.1-2929
Fentanyl .....................................................................................1584 Flunixin meglumine for veterinary use........................5.1-2929
Fentanyl citrate.........................................................................1585 Fluocinolone acetonide .......................................................... 1610
Fentanyli citras........................................................................1585 Fluocinoloni acetonidum ..................................................... 1610
Fentanylum...............................................................................1584 Fluocortolone pivalate............................................................ 1611
Fenticonazole nitrate ..............................................................1586 Fluocortoloni pivalas ............................................................. 1611
Fenticonazoli nitras ...............................................................1586 Fluorescein sodium ................................................................. 1613
Fenugreek..................................................................................1588 Fluoresceinum natricum ...................................................... 1613
Fermentation, products of ....................................................... 576 Fluorides (2.4.5.) ........................................................................ 104
Ferric chloride hexahydrate ..................................................1588 Fluorimetry (2.2.21.) ................................................................... 35
Ferri chloridum hexahydricum...........................................1588 Fluorouracil............................................................................... 1614
Ferrosi fumaras .......................................................................1589 Fluorouracilum........................................................................ 1614
Ferrosi gluconas......................................................................1590 Fluoxetine hydrochloride ....................................................... 1615
Ferrosi sulfas heptahydricus................................................ 1591 Fluoxetini hydrochloridum .................................................. 1615
Ferrous fumarate .....................................................................1589 Flupentixol dihydrochloride ...................................................1617
Ferrous gluconate....................................................................1590 Flupentixoli dihydrochloridum ............................................1617
Ferrous sulphate heptahydrate............................................. 1591 Fluphenazine decanoate ........................................................ 1619
Ferrum ad praeparationes homoeopathicas ..................... 899 Fluphenazine enantate ........................................................... 1620
Feverfew .....................................................................................1592 Fluphenazine hydrochloride ................................................. 1621
Fibrini glutinum......................................................................1593 Fluphenazini decanoas ......................................................... 1619
Fibrinogen, human .................................................................. 1740 Fluphenazini enantas............................................................ 1620
Fibrinogenum humanum ..................................................... 1740 Fluphenazini hydrochloridum ............................................ 1621
Fibrin sealant kit ......................................................................1593 Flurazepami monohydrochloridum................................... 1622
Fila non resorbilia sterilia...................................................... 874 Flurazepam monohydrochloride .......................................... 1622
Fila non resorbilia sterilia in fuso ad usum Flurbiprofen .............................................................................. 1623
veterinarium ............................................................................ 888 Flurbiprofenum ....................................................................... 1623
Fila resorbilia synthetica monofilamenta sterilia............ 880 Fluspirilene ............................................................................... 1625
Fila resorbilia synthetica torta sterilia................................ 878 Fluspirilenum .......................................................................... 1625
Filipendulae ulmariae herba ............................................... 1980 Flutamide................................................................................... 1626
Filum bombycis tortum sterile in fuso ad usum Flutamidum .............................................................................. 1626
veterinarium ............................................................................ 887 Fluticasone propionate........................................................... 1627
Filum ethyleni polyterephthalici sterile in fuso ad usum Fluticasoni propionas............................................................ 1627
veterinarium ............................................................................ 887 Flutrimazole.............................................................................. 1629
Filum lini sterile in fuso ad usum veterinarium .............. 886 Flutrimazolum ......................................................................... 1629
Foams, cutaneous ...................................................................... 608
General Notices (1) apply to all monographs and other texts 3063
Index EUROPEAN PHARMACOPOEIA 5.1
Glycinum ................................................................................... 1680 Hawthorn leaf and flower dry extract ................................. 1714
Glycyrrhizate ammonium ................................................5.1-2876 Heavy bismuth subnitrate ...................................................... 1107
Goldenrod .................................................................................. 1680 Heavy kaolin.............................................................................. 1869
Goldenrod, European.............................................................. 1682 Heavy magnesium carbonate ................................................ 1954
Goldenseal rhizome................................................................. 1683 Heavy magnesium oxide......................................................... 1958
Gonadorelin acetate ................................................................ 1684 Heavy metals (2.4.8.) ................................................................. 104
Gonadorelini acetas ............................................................... 1684 Heavy metals in herbal drugs and fatty oils (2.4.27.)..........119
Gonadotrophin, chorionic ...................................................... 1686 Hederae folium .................................................................5.1-2954
Gonadotrophin, equine serum, for veterinary use............ 1686 Helianthi annui oleum raffinatum.....................................2524
Gonadotropinum chorionicum ........................................... 1686 Heparina massae molecularis minoris ..............................1717
Gonadotropinum sericum equinum ad usum Heparin, assay of (2.7.5.) .......................................................... 195
veterinarium .......................................................................... 1686 Heparin calcium ....................................................................... 1715
Goserelin .................................................................................... 1687 Heparin in coagulation factors, assay of (2.7.12.)............... 204
Goserelinum ............................................................................. 1687 Heparins, low-molecular-mass ................................................1717
Gossypii oleum hydrogenatum............................................1370 Heparin sodium ........................................................................ 1716
Gramicidin ................................................................................. 1689 Heparinum calcicum ............................................................. 1715
Gramicidinum.......................................................................... 1689 Heparinum natricum ............................................................. 1716
Graminis rhizoma................................................................... 1371 Hepatitis A immunoglobulin, human ...................................1741
Granisetron hydrochloride..............................................5.1-2939 Hepatitis A (inactivated) and hepatitis B (rDNA) vaccine
Granisetroni hydrochloridum.......................................5.1-2939 (adsorbed).................................................................................. 664
Granulata .................................................................................... 605 Hepatitis A vaccine, assay of (2.7.14.)...........................5.1-2795
Granules ....................................................................................... 605 Hepatitis A vaccine (inactivated, adsorbed) ......................... 665
Granules, coated......................................................................... 606 Hepatitis A vaccine (inactivated, virosome) ......................... 667
Granules, effervescent............................................................... 606 Hepatitis B immunoglobulin for intravenous administration,
Granules, gastro-resistant......................................................... 606 human .......................................................................................1741
Granules, modified-release....................................................... 606 Hepatitis B immunoglobulin, human ...................................1741
Greater celandine..................................................................... 1690 Hepatitis B (rDNA), diphtheria and tetanus vaccine
Griseofulvin ............................................................................... 1691 (adsorbed).................................................................................. 641
Griseofulvinum ........................................................................ 1691 Hepatitis B (rDNA), diphtheria, tetanus and pertussis
Guaifenesin................................................................................ 1692 (acellular, component) vaccine (adsorbed) ........................ 647
Guaifenesinum ........................................................................ 1692 Hepatitis B vaccine (rDNA)...................................................... 670
Guanethidine monosulphate ................................................. 1694 Hepatitis B vaccine (rDNA), assay of (2.7.15.) ..................... 207
Guanethidini monosulfas ..................................................... 1694 Hepatitis C virus (HCV), validation of nucleic acid
Guar ............................................................................................ 1694 amplification techniques for the detection of HCV RNA in
Guar galactomannan ............................................................... 1695 plasma pools : Guidelines........................................................176
Guar galactomannanum....................................................... 1695 Heptaminol hydrochloride..................................................... 1719
Heptaminoli hydrochloridum.............................................. 1719
H Herbal drug preparations......................................................... 572
Haemodiafiltration and for haemofiltration, solutions Herbal drugs ............................................................................... 572
for .............................................................................................. 1703 Herbal drugs and fatty oils, heavy metals in (2.4.27.).........119
Haemodialysis, concentrated solutions for ........................ 1700 Herbal drugs, determination of tannins (2.8.14.) ............... 221
Haemodialysis solutions, concentrated, water for Herbal drugs for homoeopathic preparations ..................... 893
diluting..................................................................................... 1699 Herbal teas................................................................................... 573
Haemodialysis, solutions for.................................................. 1700 Hexamidine diisetionate ......................................................... 1720
Haemofiltration and for haemodiafiltration, solutions Hexamidini diisetionas ......................................................... 1720
for .............................................................................................. 1703 Hexetidine.................................................................................. 1721
Haemophilus type b (conjugate), diphtheria, tetanus, Hexetidinum............................................................................. 1721
pertussis (acellular, component) and poliomyelitis Hexobarbital.............................................................................. 1722
(inactivated) vaccine (adsorbed) ........................................... 653 Hexobarbitalum ....................................................................... 1722
Haemophilus type b (conjugate), diphtheria, tetanus, Hexosamines in polysaccharide vaccines (2.5.20.) ............. 132
pertussis and poliomyelitis (inactivated) vaccine Hexylresorcinol......................................................................... 1723
(adsorbed).................................................................................. 657 Hexylresorcinolum ................................................................. 1723
Haemophilus type b conjugate vaccine................................. 662 Hibisci sabdariffae flos .......................................................... 2376
Halofantrine hydrochloride ................................................... 1705 Highly purified water ..............................................................2695
Halofantrini hydrochloridum .............................................. 1705 Histamine (2.6.10.)..................................................................... 153
Haloperidol................................................................................ 1706 Histamine dihydrochloride .................................................... 1724
Haloperidol decanoate............................................................ 1708 Histamine phosphate .............................................................. 1725
Haloperidoli decanoas........................................................... 1708 Histamini dihydrochloridum ............................................... 1724
Haloperidolum......................................................................... 1706 Histamini phosphas................................................................ 1725
Halothane .................................................................................. 1709 Histidine..............................................................................5.1-2945
Halothanum.............................................................................. 1709 Histidine hydrochloride monohydrate ................................ 1727
Hamamelidis folium............................................................... 1711 Histidini hydrochloridum monohydricum....................... 1727
Hamamelis leaf ......................................................................... 1711 Histidinum .........................................................................5.1-2945
Hard capsules.............................................................................. 600 Homatropine hydrobromide .................................................. 1728
Hard fat ...................................................................................... 1711 Homatropine methylbromide ................................................ 1729
Hard paraffin............................................................................. 2186 Homatropini hydrobromidum ............................................. 1728
Harpagophyti radix ................................................................ 1401 Homatropini methylbromidum ........................................... 1729
Hawthorn berries ..................................................................... 1712 Homoeopathic preparations .................................................... 893
Hawthorn leaf and flower ...................................................... 1713 Homoeopathic preparations, arsenious trioxide for .......... 895
Homoeopathic preparations, common stinging nettle Hydrogenated arachis oil ....................................................... 1018
for ................................................................................................ 895 Hydrogenated castor oil ......................................................... 1197
Homoeopathic preparations, copper for............................... 896 Hydrogenated cottonseed oil ................................................1370
Homoeopathic preparations, garlic for ................................. 897 Hydrogenated soya-bean oil...................................................2475
Homoeopathic preparations, herbal drugs for .................... 893 Hydrogenated wool fat............................................................2708
Homoeopathic preparations, honey bee for......................... 898 Hydrogenii peroxidum 30 per centum.............................. 1763
Homoeopathic preparations, hypericum for ........................ 898 Hydrogenii peroxidum 3 per centum ................................ 1762
Homoeopathic preparations, iron for .................................... 899 Hydrogen peroxide solution (30 per cent) ......................... 1763
Homoeopathic preparations, mother tinctures for............. 894 Hydrogen peroxide solution (3 per cent)............................ 1762
Homoeopathic preparations, saffron for............................... 900 Hydromorphone hydrochloride ............................................ 1763
Honey ..................................................................................5.1-2946 Hydromorphoni hydrochloridum ....................................... 1763
Honey bee for homoeopathic preparations.......................... 898 Hydrous wool fat......................................................................2709
Hop strobile............................................................................... 1730 Hydroxocobalamin acetate..................................................... 1765
Human albumin injection, iodinated (125I)............................ 827 Hydroxocobalamin chloride................................................... 1766
Human albumin solution ....................................................... 1731 Hydroxocobalamini acetas ................................................... 1765
Human anti-D immunoglobulin ............................................ 1732 Hydroxocobalamini chloridum ........................................... 1766
Human anti-D immunoglobulin, assay of (2.7.13.).............. 205 Hydroxocobalamini sulfas .................................................... 1767
Human anti-D immunoglobulin for intravenous Hydroxocobalamin sulphate .................................................. 1767
administration ........................................................................ 1733 Hydroxycarbamide ................................................................... 1768
Human antithrombin III, assay of (2.7.17.)........................... 209 Hydroxycarbamidum ............................................................. 1768
Human antithrombin III concentrate .................................. 1733 Hydroxyethylcellulose......................................................5.1-2947
Human coagulation factor II, assay of (2.7.18.)................... 209 Hydroxyethylcellulosum.................................................5.1-2947
Human coagulation factor IX................................................ 1738 Hydroxyethylis salicylas........................................................ 1769
Human coagulation factor IX, assay of (2.7.11.).................. 204 Hydroxyethylmethylcellulose ................................................ 2018
Human coagulation factor VII .............................................. 1734 Hydroxyethyl salicylate........................................................... 1769
Human coagulation factor VII, assay of (2.7.10.) ................ 203 Hydroxyl value (2.5.3.) .............................................................. 127
Human coagulation factor VIII............................................. 1736 Hydroxypropylbetadex............................................................ 1771
Human coagulation factor VIII, assay of (2.7.4.)................. 194 Hydroxypropylbetadexum .................................................... 1771
Human coagulation factor VIII (rDNA)............................... 1737 Hydroxypropylcellulose .......................................................... 1773
Human coagulation factor X, assay of (2.7.19.) ....................210 Hydroxypropylcellulosum .................................................... 1773
Human coagulation factor XI................................................ 1739 Hydroxypropylmethylcellulose.............................................. 1780
Human coagulation factor XI, assay of (2.7.22.) ................. 212 Hydroxypropylmethylcellulose phthalate........................... 1781
Human fibrinogen.................................................................... 1740 Hydroxyzine hydrochloride ................................................... 1774
Human hepatitis A immunoglobulin ....................................1741 Hydroxyzini hydrochloridum .............................................. 1774
Human hepatitis B immunoglobulin ....................................1741 Hymecromone........................................................................... 1775
Human hepatitis B immunoglobulin for intravenous Hymecromonum...................................................................... 1775
administration .........................................................................1741 Hyoscine butylbromide ........................................................... 1776
Human insulin .......................................................................... 1800 Hyoscine hydrobromide.......................................................... 1777
Human measles immunoglobulin......................................... 1742 Hyoscini butylbromidum ...................................................... 1776
Human normal immunoglobulin.......................................... 1742 Hyoscini hydrobromidum..................................................... 1777
Human normal immunoglobulin for intravenous Hyoscyamine sulphate ............................................................ 1778
administration ........................................................................ 1744 Hyoscyamini sulfas ................................................................ 1778
Human plasma for fractionation........................................... 1746 Hyperici herba .........................................................................2485
Human plasma (pooled and treated for virus Hypericum .................................................................................2485
inactivation) ............................................................................ 1747 Hypericum for homoeopathic preparations ......................... 898
Human prothrombin complex............................................... 1748 Hypericum perforatum
Human rabies immunoglobulin............................................ 1750 ad praeparationes homoeopathicas................................... 898
Human rubella immunoglobulin .......................................... 1751 Hypromellose ............................................................................ 1780
Human tetanus immunoglobulin ......................................... 1751 Hypromellose phthalate ......................................................... 1781
Human varicella immunoglobulin........................................ 1752 Hypromellosi phthalas........................................................... 1781
Human varicella immunoglobulin for intravenous Hypromellosum ....................................................................... 1780
administration ........................................................................ 1753
Human von Willebrand factor, assay of (2.7.21.) .................211 I
Hyaluronidase .......................................................................... 1753 Ibuprofen ................................................................................... 1785
Hyaluronidasum ..................................................................... 1753 Ibuprofenum............................................................................. 1785
Hydralazine hydrochloride .................................................... 1754 Iceland moss.............................................................................. 1787
Hydralazini hydrochloridum ............................................... 1754 ICH (5.8.)...................................................................................... 551
Hydrargyri dichloridum ........................................................ 1995 Ichthammol ............................................................................... 1787
Hydrastis rhizoma .................................................................. 1683 Ichthammolum ........................................................................ 1787
Hydrochloric acid, concentrated........................................... 1755 Identification (2.3.) ...................................................................... 95
Hydrochloric acid, dilute ........................................................ 1756 Identification and control of residual solvents (2.4.24.).... 113
Hydrochlorothiazide................................................................ 1756 Identification of fatty oils by thin-layer chromatography
Hydrochlorothiazidum .......................................................... 1756 (2.3.2.) .......................................................................................... 98
Hydrocortisone......................................................................... 1757 Identification of phenothiazines by thin-layer
Hydrocortisone acetate........................................................... 1759 chromatography (2.3.3.) ........................................................... 99
Hydrocortisone hydrogen succinate.....................................1761 Identification reactions of ions and functional groups
Hydrocortisoni acetas............................................................ 1759 (2.3.1.)........................................................................................... 95
Hydrocortisoni hydrogenosuccinas ....................................1761 Idoxuridine ................................................................................ 1788
Hydrocortisonum .................................................................... 1757 Idoxuridinum ........................................................................... 1788
General Notices (1) apply to all monographs and other texts 3065
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3067
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3069
Index EUROPEAN PHARMACOPOEIA 5.1
Metoclopramidi hydrochloridum ........................................ 2031 Multidose containers, uniformity of mass of delivered doses
Metoclopramidum ...................................................................2030 (2.9.27.) ...................................................................................... 263
Metoprololi succinas ..............................................................2032 Mumps vaccine (live) ................................................................. 684
Metoprololi tartras ..................................................................2034 Mupirocin...................................................................................2065
Metoprolol succinate...............................................................2032 Mupirocin calcium ...................................................................2067
Metoprolol tartrate ..................................................................2034 Mupirocinum............................................................................2065
Metrifonate ................................................................................2035 Mupirocinum calcicum .........................................................2067
Metrifonatum............................................................................2035 Musci medicati........................................................................... 604
Metronidazole ...........................................................................2037 Mycobacteria (2.6.2.) ................................................................. 149
Metronidazole benzoate .........................................................2038 Mycoplasmas (2.6.7.).................................................................. 149
Metronidazoli benzoas ..........................................................2038 Myristicae fragrantis aetheroleum ..................................... 2123
Metronidazolum ......................................................................2037 Myrrh ..........................................................................................2069
Mexiletine hydrochloride........................................................2039 Myrrha .......................................................................................2069
Mexiletini hydrochloridum...................................................2039 Myrrhae tinctura .....................................................................2069
Mianserin hydrochloride ........................................................ 2041 Myrrh tincture ..........................................................................2069
Mianserini hydrochloridum ................................................. 2041 Myrtilli fructus recens............................................................ 1099
Miconazole ................................................................................2042 Myrtilli fructus siccus............................................................. 1099
Miconazole nitrate ...................................................................2043 Myxomatosis vaccine (live) for rabbits .................................. 775
Miconazoli nitras ....................................................................2043
Miconazolum............................................................................2042 N
Microbiological assay of antibiotics (2.7.2.).......................... 188 Nabumetone ..............................................................................2073
Microbiological examination of non-sterile products (test for Nabumetonum .........................................................................2073
specified micro-organisms) (2.6.13.) .................................... 156 N-Acetyltryptophan.....................................................................918
Microbiological examination of non-sterile products (total N-Acetyltryptophanum..............................................................918
viable aerobic count) (2.6.12.)............................................... 154 N-Acetyltyrosine ......................................................................... 920
Microbiological quality of pharmaceutical preparations N-Acetyltyrosinum .................................................................... 920
(5.1.4.)......................................................................................... 449 Nadolol ....................................................................................... 2074
Microcrystalline cellulose.......................................................1228 Nadololum................................................................................. 2074
Micro determination of water (2.5.32.).................................. 137 Nadroparin calcium .................................................................2075
Microscopy, limit test of particle size (2.9.13.) .................... 239 Nadroparinum calcicum .......................................................2075
Midazolam .................................................................................2045 Naftidrofuryl hydrogen oxalate.............................................2078
Midazolamum ..........................................................................2045 Naftidrofuryli hydrogenooxalas ..........................................2078
Milk-thistle fruit........................................................................2046 Nalidixic acid.............................................................................2080
Millefolii herba.........................................................................2723 Naloxone hydrochloride dihydrate.......................................2080
Minimising the risk of transmitting animal spongiform Naloxoni hydrochloridum dihydricum .............................2080
encephalopathy agents via human and veterinary medicinal Naltrexone hydrochloride................................................5.1-2979
products (5.2.8.) ....................................................................... 463 Naltrexoni hydrochloridum...........................................5.1-2979
Minocycline hydrochloride.....................................................2047 Naphazoline hydrochloride....................................................2082
Minocyclini hydrochloridum ...............................................2047 Naphazoline nitrate .................................................................2083
Minoxidil .............................................................................5.1-2974 Naphazolini hydrochloridum ..............................................2082
Minoxidilum ......................................................................5.1-2974 Naphazolini nitras ..................................................................2083
Mint oil, partly dementholised ..............................................2050 Naproxen....................................................................................2084
Mitomycin .................................................................................. 2051 Naproxenum.............................................................................2084
Mitomycinum ........................................................................... 2051 Nasal drops and liquid nasal sprays........................................610
Mitoxantrone hydrochloride..................................................2053 Nasalia ..........................................................................................610
Mitoxantroni hydrochloridum.............................................2053 Nasal powders..............................................................................611
Modified-release capsules......................................................... 600 Nasal preparations ......................................................................610
Modified-release granules ........................................................ 606 Nasal preparations, semi-solid..................................................611
Modified-release tablets ............................................................ 628 Nasal sticks...................................................................................611
Molecular mass distribution in dextrans (2.2.39.) ................ 57 Nasal washes ................................................................................611
Molgramostim concentrated solution .................................2054 Natrii acetas trihydricus ....................................................... 2415
Molgramostimi solutio concentrata ...................................2054 Natrii acetatis ([1-11C]) solutio iniectabilis ......................... 839
Mometasone furoate................................................................2057 Natrii alendronas .................................................................... 2416
Mometasoni furoas .................................................................2057 Natrii alginas ........................................................................... 2417
Monographs (1.4.)...........................................................................7 Natrii amidotrizoas ................................................................ 2418
Morantel hydrogen tartrate for veterinary use .................2059 Natrii aminosalicylas dihydricus........................................ 2419
Moranteli hydrogenotartras ad usum veterinarium......2059 Natrii ascorbas.........................................................................2420
Morphine hydrochloride.........................................................2060 Natrii benzoas.......................................................................... 2421
Morphine sulphate................................................................... 2061 Natrii bromidum......................................................................2422
Morphini hydrochloridum....................................................2060 Natrii calcii edetas ..................................................................2422
Morphini sulfas........................................................................ 2061 Natrii caprylas .........................................................................2423
Moss, Iceland ............................................................................ 1787 Natrii carbonas anhydricus...........................................5.1-3008
Mother tinctures for homoeopathic preparations .............. 894 Natrii carbonas decahydricus.......................................5.1-3008
Motherwort ...............................................................................2063 Natrii carbonas monohydricus.....................................5.1-3009
Mouthwashes .............................................................................. 612 Natrii cetylo- et stearylosulfas. ............................................2426
Moxonidine................................................................................2064 Natrii chloridum......................................................................2428
Moxonidinum...........................................................................2064 Natrii chromatis (51Cr) solutio sterilis ................................. 840
Mucoadhesive preparations ..................................................... 613 Natrii citras...............................................................................2429
Mullein flower...........................................................................2065 Natrii cromoglicas ..................................................................2429
General Notices (1) apply to all monographs and other texts 3071
Index EUROPEAN PHARMACOPOEIA 5.1
Normal immunoglobulin, human ......................................... 1742 Oral solutions, emulsions and suspensions ......................... 609
Nortriptyline hydrochloride................................................... 2120 Oral use, liquid preparations for............................................. 608
Nortriptylini hydrochloridum.............................................. 2120 Orciprenaline sulphate............................................................ 2154
Noscapine .................................................................................. 2121 Orciprenalini sulfas................................................................ 2154
Noscapine hydrochloride........................................................ 2122 Oregano...................................................................................... 2155
Noscapini hydrochloridum................................................... 2122 Organ preservation, solutions for.........................................2458
Noscapinum.............................................................................. 2121 Origani herba........................................................................... 2155
Nuclear magnetic resonance spectrometry (2.2.33.).............51 Orodispensible tablets............................................................... 628
Nucleic acid amplification techniques (2.6.21.)....................174 Oromucosal capsules ................................................................ 613
Nucleic acids in polysaccharide vaccines (2.5.17.) .............. 132 Oromucosal drops, oromucosal sprays and sublingual
Nutmeg oil ................................................................................. 2123 sprays.......................................................................................... 612
Nystatin ...................................................................................... 2124 Oromucosal preparations..........................................................611
Nystatinum ............................................................................... 2124 Oromucosal preparations, semi-solid..................................... 612
Oromucosal solutions and oromucosal suspensions ......... 612
O Orphenadrine citrate............................................................... 2156
O-Acetyl in polysaccharide vaccines (2.5.19.) ...................... 132 Orphenadrine hydrochloride................................................. 2157
Oak bark .................................................................................... 2129 Orphenadrini citras................................................................ 2156
Octoxinol 10 .............................................................................. 2129 Orphenadrini hydrochloridum............................................ 2157
Octoxinolum 10 ....................................................................... 2129 Orthosiphonis folium ............................................................. 1859
Octyldodecanol......................................................................... 2130 Oryzae amylum .......................................................................2369
Octyldodecanolum .................................................................. 2130 Osmolality (2.2.35.)...................................................................... 54
Octyl gallate .............................................................................. 2129 Other provisions applying to general chapters and
Octylis gallas ............................................................................ 2129 monographs (1.2.).........................................................................5
Odour (2.3.4.)................................................................................ 99 Ouabain...................................................................................... 2158
Odour and taste of essential oils (2.8.8.) ...............................216 Ouabainum ............................................................................... 2158
Oenotherae oleum raffinatum ......................................5.1-2921 Oxaliplatin ................................................................................. 2159
Ofloxacin.................................................................................... 2131 Oxaliplatinum .......................................................................... 2159
Ofloxacinum............................................................................. 2131 Oxazepam .................................................................................. 2162
Oils rich in omega-3- acids, composition of fatty acids Oxazepamum ........................................................................... 2162
(2.4.29.) ...................................................................................... 121 Oxeladin hydrogen citrate...................................................... 2163
Ointments .................................................................................... 625 Oxeladini hydrogenocitras ................................................... 2163
Oleae folium ............................................................................. 2134 Oxfendazole for veterinary use............................................. 2164
Olea herbaria ............................................................................ 595 Oxfendazolum ad usum veterinarium .............................. 2164
Oleic acid ................................................................................... 2132 Oxidising substances (2.5.30.)................................................. 137
Oleoyl macrogolglycerides..................................................... 2133 Oxolinic acid.............................................................................. 2165
Oleyl alcohol ............................................................................. 2134 Oxprenolol hydrochloride ...................................................... 2166
Olivae oleum raffinatum ....................................................... 2135 Oxprenololi hydrochloridum .............................................. 2166
Olivae oleum virginale .......................................................... 2136 Oxybuprocaine hydrochloride............................................... 2167
Olive leaf .................................................................................... 2134 Oxybuprocaini hydrochloridum ......................................... 2167
Olive oil, refined ....................................................................... 2135 Oxybutynin hydrochloride ..................................................... 2168
Olive oil, virgin ......................................................................... 2136 Oxybutynini hydrochloridum .............................................. 2168
Olsalazine sodium.................................................................... 2137 Oxycodone hydrochloride ...............................................5.1-2987
Olsalazinum natricum........................................................... 2137 Oxycodoni hydrochloridum ..........................................5.1-2987
Omega-3-acid ethyl esters 60................................................. 2140 Oxygen........................................................................................ 2169
Omega-3-acid ethyl esters 90................................................. 2142 Oxygen (15O) ................................................................................ 837
Omega-3 acidorum esteri ethylici 60................................. 2140 Oxygen-flask method (2.5.10.)................................................. 130
Omega-3 acidorum esteri ethylici 90................................. 2142 Oxygen in gases (2.5.27.).......................................................... 136
Omega-3 acidorum triglycerida .......................................... 2144 Oxygenium................................................................................ 2169
Omega-3-acids, composition of fatty acids in oils rich in Oxygenium (15O)........................................................................ 837
(2.4.29.) ...................................................................................... 121 Oxymetazoline hydrochloride ............................................... 2170
Omega-3-acids, fish oil rich in ...............................................1595 Oxymetazolini hydrochloridum .......................................... 2170
Omega-3-acid triglycerides ..................................................... 2144 Oxytetracycline dihydrate ...................................................... 2171
Omeprazole ............................................................................... 2146 Oxytetracycline hydrochloride .............................................. 2172
Omeprazole sodium................................................................. 2148 Oxytetracyclini hydrochloridum......................................... 2172
Omeprazolum........................................................................... 2146 Oxytetracyclinum dihydricum............................................. 2171
Omeprazolum natricum........................................................ 2148 Oxytocin ......................................................................................2174
Ondansetron hydrochloride dihydrate ................................ 2149 Oxytocin bulk solution ........................................................... 2175
Ondansetroni hydrochloridum dihydricum .................... 2149 Oxytocini solutio ..................................................................... 2175
Ononidis radix ......................................................................... 2361 Oxytocinum ...............................................................................2174
Opalescence of liquids, clarity and degree (2.2.1.) ............... 23
Ophthalmica ............................................................................... 602 P
Ophthalmic inserts .................................................................... 604 Palmitic acid.............................................................................. 2179
Opii pulvis normatus ............................................................. 2151 Pancreas powder ...................................................................... 2179
Opium crudum ........................................................................ 2152 Pancreatis pulvis ..................................................................... 2179
Opium, prepared....................................................................... 2151 Pancuronii bromidum ........................................................... 2182
Opium, raw ................................................................................ 2152 Pancuronium bromide ............................................................ 2182
Optical rotation (2.2.7.)............................................................... 28 Pansy, wild (flowering aerial parts) .....................................2700
Oral drops .................................................................................... 609 Papaverine hydrochloride ...................................................... 2183
Oral powders................................................................................617 Papaverini hydrochloridum................................................. 2183
General Notices (1) apply to all monographs and other texts 3073
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3075
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3077
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3079
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3081
Index EUROPEAN PHARMACOPOEIA 5.1
General Notices (1) apply to all monographs and other texts 3083
Index EUROPEAN PHARMACOPOEIA 5.1
Vaccinum influenzae inactivatum ex viris integris Vaccinum variolae gallinaceae vivum ............................... 766
praeparatum............................................................................. 676 Vaccinum vibriosidis ad salmonidas inactivatum ........... 797
Vaccinum influenzae inactivatum ex virorum fragmentis Vaccinum vibriosidis aquae frigidae inactivatum ad
praeparatum............................................................................. 671 salmonidas................................................................................ 796
Vaccinum laryngotracheitidis infectivae aviariae Vaccinum viri syncytialis meatus spiritus bovini vivum
vivum.......................................................................................... 727 cryodesiccatum ....................................................................... 733
Vaccinum leptospirosis bovinae inactivatum.................... 730 Vaginal capsules ......................................................................... 629
Vaccinum leptospirosis caninae inactivatum ................... 740 Vaginal foams.............................................................................. 630
Vaccinum leucosis felinae inactivatum................................761 Vaginalia ..................................................................................... 629
Vaccinum mannheimiae inactivatum ad bovidas ............ 771 Vaginal preparations ................................................................. 629
Vaccinum mannheimiae inactivatum ad ovem ................ 772 Vaginal preparations, semi-solid ............................................. 630
Vaccinum meningococcale classis C coniugatum ........... 680 Vaginal solutions and suspensions, tablets for.................... 630
Vaccinum meningococcale polysaccharidicum................ 682 Vaginal solutions, emulsions and suspensions.................... 630
Vaccinum morbi Aujeszkyi ad suem inactivatum ............ 715 Vaginal tablets ............................................................................ 629
Vaccinum morbi Aujeszkyi ad suem vivum cryodesiccatum Vaginal tampons, medicated.................................................... 630
ad usum parenterale ...............................................................717 Valerianae radix ......................................................................2667
Vaccinum morbi Carrei vivum cryodesiccatum ad canem Valerian root..............................................................................2667
..................................................................................................... 740 Validation of nucleic acid amplification techniques for the
Vaccinum morbi Carrei vivum cryodesiccatum ad detection of hepatitis C virus (HCV) RNA in plasma pools :
mustelidas................................................................................. 751 Guidelines...................................................................................176
Vaccinum morbillorum, parotitidis et rubellae vivum.... 678 Valine ..........................................................................................2668
Vaccinum morbillorum vivum............................................... 679 Valinum .....................................................................................2668
Vaccinum morbi Marek vivum .............................................. 774 Valproic acid..............................................................................2669
Vaccinum morbi partus diminutionis MCMLXXVI Vancomycin hydrochloride ....................................................2670
inactivatum ad pullum .......................................................... 753 Vancomycini hydrochloridum .............................................2670
Vaccinum myxomatosidis vivum ad cuniculum ............... 775 Vanillin .......................................................................................2672
Vaccinum panleucopeniae felinae infectivae Vanillinum ................................................................................2672
inactivatum .............................................................................. 759 Varicella immunoglobulin for intravenous administration,
Vaccinum panleucopeniae felinae infectivae vivum....... 760 human ...................................................................................... 1753
Vaccinum parainfluenzae viri bovini vivum Varicella immunoglobulin, human ....................................... 1752
cryodesiccatum ....................................................................... 732 Varicella vaccine (live)............................................................... 709
Vaccinum parainfluenzae viri canini vivum..................... 742 Vaselinum album..................................................................... 2187
Vaccinum paramyxoviris 3 aviarii inactivatum ............... 728 Vaselinum flavum ................................................................... 2188
Vaccinum parotitidis vivum ................................................... 684 Vegetable drugs, determination of essential oils in vegetable
Vaccinum parvovirosis caninae inactivatum .................... 743 drugs (2.8.12.) ...........................................................................217
Vaccinum parvovirosis caninae vivum ............................... 744 Vegetable fatty oils..................................................................... 595
Vaccinum parvovirosis inactivatum ad suem ................... 787 Verapamil hydrochloride ........................................................2673
Vaccinum pasteurellae inactivatum ad ovem.................... 783 Verapamili hydrochloridum .................................................2673
Vaccinum pertussis................................................................... 685 Verbasci flos..............................................................................2065
Vaccinum pertussis adsorbatum ........................................... 690 Veterinary liquid preparations for cutaneous application.. 630
Vaccinum pertussis sine cellulis copurificatum Vibriosis (cold-water) vaccine (inactivated) for salmonids.. 796
adsorbatum............................................................................... 688 Vibriosis vaccine (inactivated) for salmonids....................... 797
Vaccinum pertussis sine cellulis ex elementis praeparatum VICH (5.8.)................................................................................... 551
adsorbatum............................................................................... 686 Vinblastine sulphate................................................................2675
Vaccinum pestis classicae suillae vivum Vinblastini sulfas.....................................................................2675
cryodesiccatum ....................................................................... 793 Vincristine sulphate.................................................................2675
Vaccinum pneumococcale polysaccharidicum................. 691 Vincristini sulfas .....................................................................2675
Vaccinum pneumococcale polysaccharidicum coniugatum Vindesine sulphate ..................................................................2677
adsorbatum......................................................................5.1-2851 Vindesini sulfas .......................................................................2677
Vaccinum poliomyelitidis inactivatum ............................... 692 Vinorelbine tartrate ..........................................................5.1-3033
Vaccinum poliomyelitidis perorale ...................................... 695 Vinorelbini tartras............................................................5.1-3033
Vaccinum pseudopestis aviariae inactivatum................... 779 Violae herba cum flore ..........................................................2700
Vaccinum pseudopestis aviariae vivum .............................. 781 Viper venom antiserum, European ........................................ 806
Vaccinum rabiei ex cellulis ad usum humanum .............. 699 Viscometer method, capillary (2.2.9.)...................................... 29
Vaccinum rabiei inactivatum ad usum veterinarium ..... 790 Viscometer method, falling ball (2.2.49.)................................ 80
Vaccinum rabiei perorale vivum ad vulpem ...................... 792 Viscometer method, rotating (2.2.10.)..................................... 30
Vaccinum rhinitidis atrophicantis ingravescentis suillae Viscose wadding, absorbent .................................................. 2681
inactivatum .............................................................................. 788 Viscosity (2.2.8.) ........................................................................... 29
Vaccinum rhinotracheitidis infectivae bovinae vivum Visible absorption spectrophotometry (2.2.25.).................... 38
cryodesiccatum ....................................................................... 768 Visible particles, particulate contamination (2.9.20.) ........ 255
Vaccinum rhinotracheitidis viralis felinae inactivatum.. 762 Vitamin A ...................................................................................2682
Vaccinum rhinotracheitidis viralis felinae vivum Vitamin A concentrate (oily form), synthetic.....................2684
cryodesiccatum ....................................................................... 763 Vitamin A concentrate (powder form), synthetic..............2685
Vaccinum rubellae vivum ....................................................... 701 Vitamin A concentrate (solubilisate/emulsion),
Vaccinum tenosynovitidis viralis aviariae vivum ............ 729 synthetic ..................................................................................2686
Vaccinum tetani adsorbatum ................................................. 702 Vitaminum A ............................................................................2682
Vaccinum tetani ad usum veterinarium ............................. 795 Vitaminum A densatum oleosum .......................................2684
Vaccinum tuberculosis (BCG) cryodesiccatum ................. 636 Vitaminum A in aqua dispergibile .....................................2686
Vaccinum varicellae vivum .................................................... 709 Vitaminum A pulvis................................................................2685
General Notices (1) apply to all monographs and other texts 3085
Index EUROPEAN PHARMACOPOEIA 5.1